X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (254) 254
Book Review (31) 31
Conference Proceeding (21) 21
Book Chapter (9) 9
Publication (8) 8
Patent (5) 5
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (130) 130
humans (127) 127
male (84) 84
endocrinology & metabolism (82) 82
female (82) 82
middle aged (79) 79
diabetes (74) 74
type 2 diabetes (70) 70
aged (60) 60
risk factors (60) 60
adult (49) 49
diabetes mellitus, type 2 - drug therapy (47) 47
hypoglycemic agents - therapeutic use (46) 46
glucose (32) 32
cardiovascular disease (31) 31
diabetes mellitus, type 2 - blood (30) 30
double-blind method (30) 30
insulin resistance (29) 29
diabetes mellitus, type 2 - complications (27) 27
risk (27) 27
cardiovascular diseases (26) 26
hyperglycemia (25) 25
insulin (25) 25
atherosclerosis (24) 24
mortality (24) 24
drug therapy (23) 23
myocardial-infarction (23) 23
research (23) 23
blood glucose - metabolism (22) 22
cardiac & cardiovascular systems (20) 20
cardiovascular-disease (20) 20
care and treatment (20) 20
mellitus (20) 20
treatment outcome (20) 20
abridged index medicus (19) 19
clinical trials (19) 19
diabetes mellitus (18) 18
hypoglycemic agents - adverse effects (18) 18
internal medicine (18) 18
medicine & public health (18) 18
dextrose (17) 17
glucose tolerance test (17) 17
hypertension (17) 17
hypoglycemic agents - administration & dosage (17) 17
medicine, general & internal (17) 17
acarbose (16) 16
diabetes therapy (16) 16
drug therapy, combination (16) 16
health aspects (16) 16
blood pressure (15) 15
cardiovascular diseases - epidemiology (15) 15
glycated hemoglobin a - metabolism (15) 15
metabolic syndrome (15) 15
thiazolidinediones - therapeutic use (15) 15
cardiovascular diseases - etiology (14) 14
complications and side effects (14) 14
glycemic control (14) 14
prevention (14) 14
blood glucose - drug effects (13) 13
cardiovascular diseases - prevention & control (13) 13
therapy (13) 13
blood glucose - analysis (12) 12
cholesterol (12) 12
diabetes mellitus, type 2 - physiopathology (12) 12
dosage and administration (12) 12
endocrinology (12) 12
follow-up studies (12) 12
hemoglobin (12) 12
insulin - blood (12) 12
obesity (12) 12
peripheral vascular disease (12) 12
pioglitazone (12) 12
analysis (11) 11
complications (11) 11
coronary-heart-disease (11) 11
endocrinology, diabetes and metabolism (11) 11
fasting glucose (11) 11
follow-up (11) 11
hypoglycemic agents (11) 11
insulin-resistance (11) 11
intima-media thickness (11) 11
metformin - therapeutic use (11) 11
postprandial period (11) 11
prospective studies (11) 11
body mass index (10) 10
diabetes mellitus, type 2 - epidemiology (10) 10
hypoglycemia (10) 10
acarbose - therapeutic use (9) 9
biomarkers - blood (9) 9
cardiology (9) 9
cardiology and cardiovascular medicine (9) 9
fasting (9) 9
glycated hemoglobin a - analysis (9) 9
glycosylated hemoglobin (9) 9
incidence (9) 9
inflammation (9) 9
metformin (9) 9
physiological aspects (9) 9
postprandial hyperglycemia (9) 9
studies (9) 9
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, ISSN 0012-0472, 10/2005, Volume 130, Issue 42, pp. 2412 - 2412
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 373, Issue 9681, pp. 2125 - 2135
Summary Background Rosiglitazone is an insulin sensitiser used in combination with metformin, a sulfonylurea, or both, for lowering blood glucose in people... 
Internal Medicine | CARDIAC OUTCOMES | METFORMIN | MEDICINE, GENERAL & INTERNAL | MONOTHERAPY | MYOCARDIAL-INFARCTION | SULFONYLUREAS | HEART-ASSOCIATION | RISK | COMPLICATIONS | BLOOD-GLUCOSE CONTROL | FAILURE | Glycated Hemoglobin A - analysis | Myocardial Infarction - mortality | Body Weight | Metformin - therapeutic use | Prospective Studies | Humans | Middle Aged | Fractures, Bone - epidemiology | Hospitalization - statistics & numerical data | Male | Drug Utilization | Thiazolidinediones - therapeutic use | Cholesterol, LDL - blood | Female | Stroke - mortality | Drug Therapy, Combination | Heart Failure - epidemiology | Hypoglycemic Agents - therapeutic use | Administration, Oral | Sulfonylurea Compounds - therapeutic use | Angina, Unstable - epidemiology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Sex Factors | Cholesterol, HDL - blood | Diuretics - therapeutic use | Diabetes Mellitus, Type 2 - drug therapy | Neoplasms - epidemiology | Type 2 diabetes | Patient outcomes | Dosage and administration | Drug therapy, Combination | Research | Metformin | Rosiglitazone maleate | Drug therapy | Health aspects | Heart failure | Studies | Clinical trials | Data collection | Blood pressure | Diabetes | Marketing | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | MEDICINE | Medicin och hälsovetenskap | MEDICIN
Journal Article
Journal Article
Journal Article
Diabetes Care, ISSN 0149-5992, 02/2012, Volume 35, Issue 2, pp. 252 - 258
Journal Article
Journal Article
Expert Review of Endocrinology and Metabolism, ISSN 1744-6651, 07/2012, Volume 7, Issue 4, pp. 395 - 405
Journal Article
Diabetes Care, ISSN 0149-5992, 08/2016, Volume 39, Issue 8, pp. 1318 - 1328
Journal Article
Journal Article